Physician profile
Vikas Goyal
NPI 1275853327
$386.08
in general payments reported to CMS, 2019-2025
10 companies · $117 in 2025
The $117 reported for 2025 was less than what a typical Critical Care Medicine (Internal Medicine) provider received nationally (typical 2025 total: $189).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $51.02 · 2023: $129 · 2024: $88.61 · 2025: $117.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $335.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $335.06 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Aroa Biosurgery Incorporated | $81.05 | 2022-2023 | |
| Merck Sharp & Dohme LLC | $75.64 | 2023-2025 | Zerbaxa, Dificid, Recarbrio |
| Csl Behring | $66.69 | 2023 | Kcentra, Berinert |
| Shionogi INC | $29.38 | 2025 | Fetroja |
| Acera Surgical, INC. | $28.66 | 2025 | Restrata Wound Matrix |
| Teleflex LLC | $27.00 | 2024 | Arrow |
| Alcresta Therapeutics, INC. | $23.72 | 2024 | Relizorb |
| Astrazeneca Pharmaceuticals LP | $20.80 | 2024 | |
| Abbvie INC. | $17.09 | 2024 | |
| Pfizer INC. | $16.05 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Vikas Goyal listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.